Regulatory T cells as modulators of B cell antibody production

Clinical Immunology

Volumn 140, Issue 3, 2011, Pages 216-217

  Crispín, José C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIBODY; HEPATITIS B VACCINE;

ANTIBODY PRODUCTION; ANTIBODY TITER; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CELL SURVIVAL; EDITORIAL; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IDIOPATHIC THROMBOCYTOPENIC PURPURA; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSIENT HYPOGAMMAGLOBULINEMIA OF INFANCY;

AGAMMAGLOBULINEMIA; HUMANS; T-LYMPHOCYTES, REGULATORY;

EID: 80051783760     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.05.006     Document Type: Editorial

References (20)

1. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell May 30 2008, 133(5):775-787.
2. Tang Q., Bluestone J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. Mar 2008, 9(3):239-244.
3. Ochs H.D., Ziegler S.F., Torgerson T.R. FOXP3 acts as a rheostat of the immune response. Immunol. Rev. Feb 2005, 203:156-164.
4. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. Jan 2001, 27(1):68-73.
5. Cvetanovich G.L., Hafler D.A. Human regulatory T cells in autoimmune diseases. Curr. Opin. Immunol. Dec 2010, 22(6):753-760.
6. Zhao D.M., Thornton A.M., DiPaolo R.J., Shevach E.M. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood May 15 2006, 107(10):3925-3932.
7. Ludwig-Portugall I., Hamilton-Williams E.E., Gottschalk C., Kurts C. Cutting edge: CD25+ regulatory T cells prevent expansion and induce apoptosis of B cells specific for tissue autoantigens. J. Immunol. Oct 1 2008, 181(7):4447-4451.
8. Ludwig-Portugall I., Hamilton-Williams E.E., Gotot J., Kurts C. CD25+ T(reg) specifically suppress auto-Ab generation against pancreatic tissue autoantigens. Eur. J. Immunol. Jan 2009, 39(1):225-233.
9. Jang E., Cho W.S., Cho M.L., Park H.J., Oh H.J., Kang S.M., et al. Foxp3+ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells. J. Immunol. Feb 1 2011, 186(3):1546-1553.
10. Hsu W.T., Suen J.L., Chiang B.L. The role of CD4CD25 T cells in autoantibody production in murine lupus. Clin. Exp. Immunol. Sep 2006, 145(3):513-519.
11. Iikuni N., Lourenco E.V., Hahn B.H., La Cava A. Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus. J. Immunol. Aug 1 2009, 183(3):1518-1522.
12. Tsuda M., Torgerson T.R., Selmi C., Gambineri E., Carneiro-Sampaio M., Mannurita S.C., et al. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J. Autoimmun. Nov 2010, 35(3):265-268.
13. Leonardo S.M., Josephson J.A., Hartog N.L., Gauld S.B. Altered B cell development and anergy in the absence of Foxp3. J. Immunol. Aug 15 2010, 185(4):2147-2156.
14. + T lymphocytes is transiently elevated in the early childhood of transient hypogammaglobulinemia of infancy patients. Clin. Immunol. 2011, 140:307-310.
15. del Pozo Balado M.M., Leal M., Mendez Lagares G., Mata R.C., Lopez-Cortes L.F., Viciana P., et al. Increased regulatory T cell counts in HIV-infected nonresponders to hepatitis B virus vaccine. J. Infect. Dis. Aug 15 2010, 202(3):362-369.
16. Liu B., Zhao H., Poon M.C., Han Z., Gu D., Xu M., et al. Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura. Eur. J. Haematol. Feb 2007, 78(2):139-143.
17. Ling Y., Cao X., Yu Z., Ruan C. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur. J. Haematol. Oct 2007, 79(4):310-316.
18. Stasi R., Cooper N., Del P.G., Stipa E., Laura E.M., Abruzzese E., et al. Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood Aug 15 2008, 112(4):1147-1150.
19. Li Z., Mou W., Lu G., Cao J., He X., Pan X., et al. Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia. Int. J. Hematol. Jan 2011, 93(1):91-98.
20. Bao W., Bussel J.B., Heck S., He W., Karpoff M., Boulad N., et al. Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood Nov 25 2010, 116(22):4639-4645.